SEC Form 4 · accession 0001171843-17-004784
Sucampo Pharmaceuticals, Inc. · SCMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jones W. Bryan
Officer — Sr. Vice Pres., BD & Licensing
Period of report
Aug 4, 2017
Accepted (ET)
Aug 7, 2017 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001365216
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, Class A | Aug 4, 2017 | P | 4,700 | $10.60 | A | 4,700 | D |
Table II — derivative securities
No Table II lines on this filing.